Agilent Technologies, Inc. which can be found using ticker (A) now have 17 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $165.00 and $125.00 suggesting an average analyst share price target price of $145.89. (at the time of writing). Now with the previous closing price of $145.56 this would indicate that there is a potential upside of .2%. The day 50 moving average is $139.08 and the 200 moving average now moves to $125.49. The market capitalization for the company is 42.25B. The stock price for the company is currently is currently $144.17 USD
The potential market cap would be $42,345,524,942 based on the market consensus.
The company has a dividend yield of 2.35%. Other points of data to note are a P/E ratio of 34.49, revenue per share of $22.97 and a 7.85% return on assets.
Agilent Technologies, Inc. is engaged in providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. It operates in the life sciences, diagnostics and applied chemical markets. Its life sciences and applied markets business offers application-focused solutions that include instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics businesses are comprised of six areas of activity, providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. Its product categories include liquid chromatography systems and components and liquid chromatography mass spectrometry systems.
